首页> 外文会议>National meeting of the American Chemical Society >Developing Influenza Antigen Microarrays for Seroprofiling
【24h】

Developing Influenza Antigen Microarrays for Seroprofiling

机译:制育血清化型流感抗原微阵列

获取原文

摘要

Peptide and protein microarrays remain under-exploited tools in dissecting the immunogenic profiles of infections. Though antibody arrays have been conveniently developed for multiplexed detection of pathogenic contaminants in biological and environmental samples, it has perhaps been a greater challenge to produce antigen arrays, containing immunogenic peptide epitopes, for the detection of host exposure to infection. Herein we describe the development of such an antigen microarray platform against influenza, for potential applications in diagnostics, epitope mapping and potentially vaccine development. We have thus far successfully expressed a collection of 8 haemagglutinins (HAs) and 2 H1N1 targets for immobilization onto microarrays. This has been successful in yielding microarray binding profiles with anti-influenza antibodies spiked in human serum. We aim to expand on our antigen panel and build a wider influenza proteome array to aid in the serodiagnostics of influenza infections.
机译:肽和蛋白质微阵列仍然是疏忽疏忽疏忽感染的免疫原性谱的工具。尽管在生物和环境样品中的致病污染物的多重检测中,抗体阵列已经方便地发展,但是对于产生含有免疫原性肽表位的抗原阵列,它可能是更大的挑战,用于检测宿主暴露于感染。在此,我们描述了这种抗原微阵列平台的发展,用于诊断,表位映射和潜在疫苗发育中的潜在应用。迄今为止,我们已经成功地表达了8种血凝素(具有)和2 H1N1的固定到微阵列上的靶标的集合。这一直成功地产生微阵列结合谱,抗流感抗体掺入人血清。我们的目标是扩展我们的抗原面板,并建立更广泛的流感蛋白质组阵列,以帮助流感感染的血清诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号